Magenta Therapeutics
$6.189876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$6.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.26 (-4.04%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours
Why Robinhood?
You can buy or sell MGTA and other stocks, options, ETFs, and crypto commission-free!
About MGTA
Magenta Therapeutics, Inc. Common Stock, also called Magenta Therapeutics, is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants. Read More It offers platform that focuses on critical areas of transplant medicine. The company was founded by David Scadden, Derrick Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner in June 2015 and is headquartered in Cambridge, MA.
Employees
72
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
246.58M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
313.59K
High Today
$6.50
Low Today
$6.02
Open Price
$6.39
Volume
143.47K
52 Week High
$18.40
52 Week Low
$5.76
Collections
MGTA Earnings
-$0.67
-$0.45
-$0.22
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, Pre-Market